Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Triple Negative Breast Neoplasms 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Waldenstrom Macroglobulinemia 1 Toxoplasmosis 1 Thrombocytosis 1 Recurrence 1 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Myeloproliferative Disorders 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

Cyclophosphamide 115 Dexamethasone 70 fludarabine phosphate 57 Cytarabine 56 fludarabine 52 Rituximab 51 Peripheral Blood Stem Cell Transplantation 40 Etoposide 40 Gemcitabine 39 Lenalidomide 38 pembrolizumab 33 Radiotherapy 33 Busulfan 33 Filgrastim 32 Carboplatin 31 Methotrexate 30 Cyclosporine 29 Cisplatin 29 Bortezomib 29 Mycophenolic Acid 28 Melphalan 28 venetoclax 27 Paclitaxel 26 Whole-Body Irradiation 24 Antilymphocyte Serum 23 Temozolomide 22 Granulocyte Colony-Stimulating Factor 20 Calcium Dobesilate 20 Bevacizumab 20 Tacrolimus 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Recurrence × Base Sequence × Clear all

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡